National science prize goes to Arab-Israeli professor for cancer and Parkinson’s breakthroughs

Prof. Ashraf Brik, a chemistry professor from the Technion – Israel Institute of Technology, has been awarded the Rappaport Prize for Excellence in Biomedical Research. This recognition is for his significant contributions to developing protein-based treatments for cancer and Parkinson’s disease, aiming to enhance health and human welfare.

In his acceptance speech, Brik stated, “Scientists like myself seek to uncover the mysteries of nature. Sometimes, I’m the first to discover something, helping push humanity forward.” Brik, who is from northern Israel and the first Arab chemistry professor in the country, highlighted that he is one of ten siblings, the only one to have pursued higher education. He believes his success can serve as a source of motivation for young Arab-Israelis to aim high.

He also reflected on the role of science in bridging cultural divides, saying, “As a professor at the Technion, in a lab with both Arabs and Jews, I see how science brings them together. That’s the beauty of science, it unites people, regardless of their backgrounds. It’s about contributing to humanity at large, not just to one specific society.”

The Rappaport Prize is awarded each year by the Bruce and Ruth Rappaport Foundation, recognizing achievements in three distinct areas: Israeli art, innovative biomedical research, and women creating change. The awards for art and women generating change are given in collaboration with the Tel Aviv Museum of Art and the Keshet media group, respectively.

* Israel21C contributed to this article.